Indicators of bacterial infection in patients with acute exacerbation of chronic bronchitis for application in clinical trials of antibacterial drugs

Journal of Infection

Volumn 55, Issue 3, 2007, Pages 226-232

  Burley, C J ^a   Masterton, R G ^b   Lovell, D P ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b CROSSHOUSE HOSPITAL   (United Kingdom)

Author keywords

Acute bacterial exacerbation of chronic bronchitis; Chronic bronchitis; Clinical trials; Indicators of infection; Lower respiratory tract infection

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; AGED; ARTICLE; BACTERIAL CELL; BACTERIAL INFECTION; BACTERIUM CULTURE; CELL COUNT; CELL TYPE; CHRONIC BRONCHITIS; COLIFORM BACTERIUM; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; ENTEROCOCCUS FAECALIS; EPITHELIUM CELL; FEMALE; GRAM STAINING; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS PARAINFLUENZAE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MICROSCOPY; MORAXELLA CATARRHALIS; PREDICTION; PSEUDOMONAS AERUGINOSA; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SPUTUM ANALYSIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; SYMPTOM;

ADULT; AGED; AGED, 80 AND OVER; BACTERIA; BACTERIAL INFECTIONS; BACTERIOLOGICAL TECHNIQUES; BRONCHITIS, CHRONIC; CLINICAL TRIALS; DISEASE PROGRESSION; DYSPNEA; FEMALE; GENTIAN VIOLET; HUMANS; MALE; MIDDLE AGED; PHENAZINES; SENSITIVITY AND SPECIFICITY; SPUTUM; STAINING AND LABELING; SUPPURATION;

EID: 34547839180     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2007.05.181     Document Type: Article

References (24)

1. American Thoracic Society. Chronic bronchitis, asthma, and pulmonary emphysema. A statement by the Committee on Diagnostic Standards for Nontuberculous Respiratory Diseases. Am Rev Respir Dis 85 (1962) 762-768
2. Sethi S. Infectious etiology of acute exacerbations of chronic bronchitis. Chest 117 Suppl (2000) S380-S385
3. Fagon J.Y., Chastre J., Trouillet J.L., et al. Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis: use of the protected specimen brush technique in 54 mechanically ventilated patients. Am Rev Respir Dis 142 (1990) 1004-1008
4. Miravitlles M., Espinosa C., Fernandez-Laso E., et al. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Chest 116 (1999) 40-46
5. Langan C., Clecner B., Cazzola C.M., Brambilla C., Holmes C.Y., and Staley H. Short-course cefuroxime axetil therapy in the treatment of acute exacerbation of chronic bronchitis. Int J Clin Pract 52 (1998) 289-297
6. Schaberg T., Ballin I., Huchon G., et al. A multinational, multicentre, non-blinded randomized study of moxifloxacin oral tablets compared with co-amoxiclav oral tablets in the treatment of acute exacerbation of chronic bronchitis. J Int Med Res 29 (2001) 314-328
7. Wilson R., Schentag J.J., Ball P., Mandell L., and Study Group. A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes. Clin Ther 24 (2002) 639-652
8. File T., Schemmler B., Garau J., et al. Gemifloxacin versus amoxicillin/clavulanate in the treatment of acute exacerbations of chronic bronchitis. J Chemother 12 (2000) 314-325
9. DeAbate C.A., Myers D., Henry D., et al. Efficacy and tolerability of once-daily grepafloxacin compared with clarithromycin in the treatment of acute bacterial exacerbation of chronic bronchitis. Clin Drug Invest 17 (1999) 21-31
10. Anthonisen N.R., Manfreda J., Warren C.P.W., et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Int Med 106 (1987) 196-204
11. Periti P., Novelli A., Schildwachter G., et al. Efficacy and tolerance of cefpodoxime proxetil compared with co-amoxiclav in the treatment of exacerbations of chronic bronchitis. J Antimicrob Chemother 26 Suppl E (1990) 63-69
12. Rademaker C.M.A., Sips A.P., Beumer H.M., et al. A double-blind comparison of low-dose ofloxacin and amoxicillin/clavulanic acid in acute exacerbations of chronic bronchitis. J Antimicrob Chemother 26 Suppl D (1990) 75-81
13. Zervos M.J., Heyder A.M., and Leroy B. Oral telithromycin 800 mg once daily for 5 days versus cefuroxime axetil 500 mg twice daily for 10 days in adults with acute exacerbations of chronic bronchitis. J Int Med Res 31 (2003) 157-169
14. Wilson R., Allegra L., Huchon G., et al. Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis. Chest 125 (2004) 953-964
15. Starakis I., Gogos C.A., and Bassaris H. Five-day moxifloxacin therapy compared with 7-day co-amoxiclav therapy for the treatment of acute exacerbation of chronic bronchitis. Int J Antimicrob Agents 23 (2004) 129-137
16. Shah P., Maesen F.P., Dolmann A., Vetter N., Fiss E., and Wesch R. Levofloxacin versus cefuroxime axetil in the treatment of acute exacerbation of chronic bronchitis: results of a randomized, double-blind study. J Antimicrob Chemother 43 (1999) 529-539
17. Chodosh S., DeAbate C.A., Haverstock D., Aneiro L., and Church D. Short course moxifloxacin therapy for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group. Respir Med 94 (2000) 18-27
18. Geckler R.W., Gremillion D.H., McAllister C.K., and Ellenbogen C. Microscopic and bacteriological comparison of paired sputa and transtracheal aspirates. J Clin Microbiol 6 (1977) 396-399
19. Wilson R., Kubin R., Ballin I., et al. Five-day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbation of chronic bronchitis. J Antimicrob Chemother 44 (1999) 501-513
20. Stockley R.A., O'Brien C., Pye A., and Hill S.L. Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. Chest 117 (2000) 1638-1645
21. Soler N., Agusti C., Angrill J., Puig de la Bellacasa J., and Torres A. Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary disease. Thorax 62 (2007) 29-35
22. Eller J., Ede A., Schaberg T., Niederman M.S., Mauch H., and Lode H. Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function. Chest 113 (1998) 1542-1548
23. Chodosh S. Treatment of acute exacerbations of chronic bronchitis: state of the art. Am J Med 91 Suppl 6A (1991) 87-92
24. van der Valk P., Monninkhof E., van der Palen J., van Herwaarden C., and Hendrix R. Clinical predictors of bacterial involvement in exacerbations of chronic obstructive pulmonary disease. Clin Infect Dis 39 (2004) 980-986